The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Okino, Alessandra M ^a,b   Bürger, Cristiani ^b,c   Cardoso, Jefferson R ^a   Lavado, Edson L ^a   Lotufo, Paulo A ^b   Campa, Ana ^b  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; PLASMA PROTEIN; SERUM AMYLOID A;

ARTICLE; ASCITES FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EXUDATE; HUMAN; INFLAMMATION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ASCITES; METABOLISM; PLEURA EFFUSION; SENSITIVITY AND SPECIFICITY; TIME;

ACUTE-PHASE PROTEINS; ASCITES; BIOLOGICAL MARKERS; BLOOD PROTEINS; C-REACTIVE PROTEIN; EXUDATES AND TRANSUDATES; HUMANS; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 33645236162     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/47297     Document Type: Article

References (36)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine. 1999;340(6):448-154.
2. Upragarin N, Landman WJ, Gaastra W, Gruys E. Extrahepatic production of acute phase serum amyloid A. Histology and Histopathology. 2005;20(4:):1295-307.
3. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990;12(5):1179-1186.
4. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clinical Chemistry. 1993;39(2):293-297.
5. Lannergard A, Larsson A, Kragsbjerg P, Friman G. Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scandinavian Journal of Clinical and Laboratory Investigation. 2003;63(4):267-272.
6. Huttunen T, Teppo AM, Lupisan S, Ruutu P, Nohynek H. Correlation between the severity of infectious diseases in children and the ratio of serum amyloid A protein and C-reactive protein. Scandinavian Journal of Infectious Diseases. 2003;35(8):488-490.
7. Mayer JM, Raraty M, Slavin J, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. The British Journal of Surgery. 2002;89(2):163-171.
8. Maury CP. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clinical Science (London). 1985;68(2):233-238.
9. Yilmaz Turay U, Yildirim Z, Turkoz Y, et al. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions. Respiratory Medicine. 2000;94(5):432-435.
10. Castano Vidriales JL, Amores Antequera C. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions. The European Journal of Medicine. 1992;1(4):201-207.
11. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Annals of Internal Medicine. 1972;77(4):507-513.
12. Vives M, Porcel JM, Vicente de Vera M, Ribelles E, Rubio M. A study of Light's criteria and possible modifications for distinguishing exudative from transudative pleural effusions. Chest. 1996;109(6):1503-1507.
13. Romero S, Candela A, Martin C, Hernandez L, Trigo C, Gil J. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest. 1993;104(2):399-404.
14. Hamm H, Brohan U, Bohmer R, Missmahl HP. Cholesterol in pleural effusions. A diagnostic aid. Chest. 1987;92(2):296-302.
15. Burgess LJ, Maritz FJ, Taljaard JJF. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest. 1995;107(6):1604-1609.
16. Paramothayan NS, Barron J. New criteria for the differentiation between transudates and exudates. Journal of Clinical Pathology. 2002;55(1):69-71.
17. Chait A, Han CY, Oram JF, Heinecke JW. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? Journal of Lipid Research. 2005;46(3):389-403.
18. Agrawal A. CRP after 2004. Molecular Immunology. 2005;42(8):927-930.
19. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. The American Journal of Pathology. 1994;145(3):650-660.
20. + T-lymphocytes. FEBS Letters. 2000;472(2-3):259-262.
21. Silverman SL, Cathcart ES, Skinner M, Cohen AS. The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase. Immunology. 1982;46(4):737-744.
22. Hayat S, Raynes JG. Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line. Scandinavian Journal of Immunology. 2000;51(2):141-146.
23. Badolato R, Wang JM, Murphy WJ, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. The Journal of Experimental Medicine. 1994;180(1):203-209.
24. Robey FA, Ohura K, Futaki S, et al. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. The Journal of Biological Chemistry. 1987;262(15):7053-7057.
25. Kuta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. The Journal of Experimental Medicine. 1986;164(1):321-326.
26. Furlaneto CJ, Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil. Biochemical and Biophysical Research Communications. 2000;268(2):405-408.
27. Ribeiro FP, Furlaneto CJ, Hatanaka E, et al. mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators of Inflammation. 2003;12(3):173-178.
28. Hatanaka E, Furlaneto CJ, Ribeiro FP, Souza GM, Campa A. Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunology Letters. 2004;91(1):33-37.
29. Furlaneto CJ, Ribeiro FP, Hatanaka E, Souza GM, Cassatella MA, Campa A. Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids. 2002;37(9):925-928.
30. Hatanaka E, Ribeiro FP, Campa A. The acute phase protein serum amyloid A primes neutrophils. FEMS Immunology and Medical Microbiology. 2003;38(1):81-84.
31. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Current Opinion in Hematology. 2000;7(1):64-69.
32. Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure with Folding & Design. 1999;7(2):169-177.
33. Volanakis JE. Human C-reactive protein: expression, structure, and function. Molecular Immunology. 2001;38(2-3):189-197.
34. Garcia-Pachon E, Llorca I. Diagnostic value of C-reactive protein in exudative pleural effusions. European Journal of Internal Medicine. 2002;13(4):246-249.
35. Roth BJ, O'Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest. 1990;98(3):546-549.
36. Valdes L, Pose A, Suarez J, et al. Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest. 1991;99(5):1097-1102.